Prosecution Insights
Last updated: October 02, 2026

Examiner: ARIETI, RUTH SOPHIA

Tech Center 1600 • Art Units: 1600 1635 1636 1674

This examiner grants 47% of resolved cases

Analysis

Ruth Sophia Arieti is an examiner in Tech Center 1600 with 89 resolved cases. Her allowance rate is 46.1 percent. This 46.1 percent rate indicates the frequency of granted patents among the 89 resolved cases. Practitioners can use these figures to evaluate the prosecution environment in this tech center. The record of 89 resolved cases provides a basis for analyzing the examiner's past actions and success rates.

The interview lift is 70.7 percent, which is a statistic that shows the change in allowance probability following an interview. This 70.7 percent lift is a metric for developing a strategy. The median days to allowance is 1239, providing a benchmark for the time required to reach a grant. This 1239-day median is a data point for managing expectations. These figures from Tech Center 1600 serve as the basis for understanding the examiner's historical performance and the duration of the prosecution cycle.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

46.7%
Allow Rate
-13.3% vs TC avg
130
Total Applications
+71.1%
Interview Lift
1245
Avg Prosecution Days
Based on 90 resolved cases, 2023–2026

Rejection Statute Breakdown

5.3%
§101 Eligibility
12.9%
§102 Novelty
30.5%
§103 Obviousness
28.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17836265 Modified Guide RNAs for Gene Editing Final Rejection Intellia Therapeutics, Inc.
16999759 O-METHYL RICH FULLY STABILIZED OLIGONUCLEOTIDES Non-Final OA UNIVERSITY OF MASSACHUSETTS
18558886 USE OF CHEMICAL EPIGENETIC MODIFIERS TO MODULATE GENE EXPRESSION FROM VECTORS Non-Final OA The University of North Carolina at Chapel Hill
18310891 ALKENYL SUBSTITUTED 2,5-PIPERAZINEDIONES, COMPOSITIONS, AND USES THEREOF Non-Final OA Massachusetts Institute of Technology
18283699 TARGETING MULTIPLE T CELL TYPES USING SPHERICAL NUCLEIC ACID VACCINE ARCHITECTURE Non-Final OA NORTHWESTERN UNIVERSITY
18248974 RNA COMPOSITIONS AND METHODS FOR INHIBITING LIPOPROTEIN(A) Final Rejection SANOFI
18037029 SUPPRESSING HIPPO SIGNALING IN THE STEM CELL NICHE PROMOTES SKELETAL MUSCLE REGENERATION Final Rejection Texas Heart Institute
17127773 METHODS AND MATERIALS FOR CLONING FUNCTIONAL T CELL RECEPTORS FROM SINGLE T CELLS Non-Final OA University of Pittsburgh - Of the Commonwealth System of Higher Education
18033049 DUAL AAV VECTOR-MEDIATED DELETION OF LARGE MUTATIONAL HOTSPOT FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY Non-Final OA Duke University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month